Hepatitis Model
Hepatitis Model
HuaTeng Biotechnology provides a versatile preclinical platform for evaluating acute and chronic hepatitis, covering diverse etiologies including T-cell-mediated autoimmunity, acute cytokine storm, and chemical hepatotoxicity. By establishing tightly controlled in vivo models, we replicate clinical intrahepatic immune infiltration, parenchymal necrosis, and systemic inflammatory cascades.
Modeling Methodologies
1. Concanavalin A (ConA)-Induced Immune-Mediated Hepatitis
Administration of ConA selectively recruits and activates T-lymphocytes and Natural Killer T (NKT) cells within the liver. This triggers rapid systemic release of pro-inflammatory cytokines and localized hepatic necrosis, serving as the gold-standard preclinical model for human autoimmune hepatitis (AIH) and immune-driven liver injury.
2. D-Galactosamine / Lipopolysaccharide (D-GalN/LPS) Fulminant Hepatitis
Co-administration of D-GalN and endotoxin (LPS) sensitizes hepatocytes to TNF-α-mediated apoptosis and systemic inflammatory response. This regimen mimics acute, fulminant hepatic failure characterized by severe apoptotic damage and rapid elevation of serum transaminases.
3. Chemical & Toxicant-Induced Acute Hepatitis
Utilizing acute hepatotoxin protocols (such as Acetaminophen/APAP or low-dose CCl4 challenge) to induce acute centrilobular necrosis and oxidative toxicity, providing a rapid platform for screening direct hepatoprotective and anti-apoptotic agents.
Clinical Relevance & Translation
- Immune Microenvironment Mimicry: The ConA model recapitulates human T-cell/NKT-cell activation pathways, crucial for evaluating targeted biologics and immunosuppressants.
- Apoptotic vs. Necrotic Pathways: Dual modeling options allow precise differentiation between anti-apoptotic mechanisms (D-GalN/LPS) and anti-necrotic/antioxidant activities (toxicant models).
- Cytokine Storm Dynamics: Accurately reflects hyper-inflammatory signaling cascades seen in acute clinical liver injury and post-viral immune dysfunction.
Key Evaluation Endpoints
| Endpoint Domain | Specific Parameters & Assays | Pathological Significance |
|---|---|---|
| Serum Biochemistry & Injury Markers | • ALT, AST, LDH • Total Bilirubin (TBIL) • Serum Albumin & Total Protein |
Measures systemic acute liver cell damage, membrane permeability loss, and functional hepatic reserve. |
| Inflammatory & Cytokine Profiling | • TNF-α, IFN-γ, IL-6, IL-1β • Chemokines (MCP-1 / CCL2) • Myeloperoxidase (MPO) Activity |
Quantifies systemic and intrahepatic inflammatory response and immune cell recruitment intensity. |
| Histopathology & Cell Fate | • H&E Staining (Necrosis Scoring) • TUNEL Assay (Apoptosis Index) • IHC (CD3+, F4/80+ Infiltration) |
Evaluates parenchymal tissue disruption, apoptotic cell death rates, and immune cell localization. |
| Oxidative Stress & Molecular Targets | • MDA, GSH/GSSG Ratio, SOD • NF-κB & MAPK Pathway Activation • Caspase-3 / Caspase-9 Cleavage |
Determines antioxidant capacity and pinpoints molecular signaling mechanisms under therapeutic intervention. |
Related Animal Models
Explore other gene-edited animal models that complement our porcine research platforms
